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Associations of steps per day and step
intensity with the risk of diabetes: the Hispanic
Community Health Study / Study of Latinos
(HCHS/SOL)
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Yasmin Mossavar‑Rahmani3, Jordan A. Carlson4, Linda C. Gallo5, Maria M. Llabre6, Olga L. Garcia‑Bedoya7,
David Goldsztajn Farelo8 and Kelly R. Evenson1

Abstract
Background: Higher levels of moderate-to-vigorous physical activity have been associated with a lower risk of
diabetes, but less is known about how daily step counts (steps/day) are associated with diabetes risk. Therefore, we
examined the association of steps/day and step intensity with incident diabetes.
Methods: We included 6634 adults from the population-based prospective cohort Hispanic Community Health
Study/Study of Latinos (HCHS/SOL) (2008–2017). Cox proportional hazard models that accounted for complex survey
design and sampling weights were used to estimate the association of baseline accelerometer-assessed steps/day
and step intensity with 6-year risk of incident diabetes as hazard ratios (HR) and 95% confidence intervals (CI). We
further examined whether the percent of intense steps at a given accumulation of steps/day was associated with
diabetes risk, and if associations were modified by specific cohort characteristics.
Results: The average age of cohort members was 39 years and 52% were female. Adults had an average of 8164
steps/day and spent 12 min/day in brisk ambulation (> 100 steps/min). Over 6 years of follow-up, there were 1115
cases of diabetes. There was a suggestive lower risk of diabetes with more steps/day– adults had a 2% lower risk per
1000 steps/day (HR = 0.98 (95% CI 0.95, 1.00)). Inverse associations between average steps/day and diabetes inci‑
dence were observed across many cohort characteristics, but most importantly among adults at high risk for diabe‑
tes – those who were older, or had obesity or prediabetes. Adults who accumulated 17 min/day in brisk ambulation
compared to < 2 min/day had a 31% lower risk of diabetes (HR = 0.69 (95% CI 0.53, 0.89)). A greater percent of intense
steps for a given accumulation of steps/day was associated with further risk reduction.
Conclusion: Adults who accumulate more daily steps may have a lower risk of diabetes. Accumulating more steps/
day and greater step intensity appear to be important targets for preventing diabetes.
Keywords: Steps per day, Step cadence, Diabetes, Physical activity, Hispanic/Latino, Cohort, Epidemiology
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Background
In the United States (US), over 26 million adults (9.8%)
have a diagnosis of type 2 diabetes and 91.8 million
(37.6%) have prediabetes [1]. Diabetes is associated with
significant morbidity and mortality [2], and will remain a
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large public health burden, as the prevalence of diabetes
is projected to double by 2030 [3]. One preventive strategy advocated by the American Diabetes Association is
engagement in moderate-to-vigorous physical activity
(MVPA) [4]. Higher levels of MVPA have been associated
with a lower risk of diabetes [5–8]. While most evidence
relies on self-reported and accelerometer-measured
MVPA, less is known about how daily step counts are
related to diabetes. Daily step counts are an easily interpretable, trackable, and simple measure of physical activity volume and have become more familiar and accessible
to the public with the increase in wearable devices [9]. In
2018, the US Physical Activity Guidelines Advisory Committee reviewed studies on step counts with health outcomes and determined there was insufficient evidence on
the association of step counts with mortality, cardiovascular disease, and diabetes [9, 10]. The Committee called
for more longitudinal research on the association of step
counts and stepping cadence with health outcomes [9].
Since 2018, new studies have been published that suggest
greater steps per day are associated with a lower risk of
all-cause mortality [11–14]. However, there remains limited data on how daily steps counts are associated with
diabetes risk.
Total step volume (steps/day) includes steps accumulated at a light, moderate, and vigorous intensity [9]. The
rate of stepping, or cadence (steps/min), is considered
a proxy for walking intensity and a directly-observed
cadence of > 100 steps/min is suggested to be a moderate intensity activity or greater (≥ 3 metabolic equivalents) [15]. Four longitudinal studies have examined the
association of steps/day with diabetes or incident dysglycemia (impaired fasting glucose or impaired glucose tolerance) [16–19]. In the NAVIGATOR Trial, participants
had a 4% lower risk of diabetes per 2000 steps/day [16].
In three other cohorts, the Australian Diabetes, Obesity
and Lifestyle Study (AusDiab), Healthy Aging Initiative
cohort in Northern Sweden, and the Women’s Health
Initiative Objective Physical Activity and Cardiovascular
Health (OPACH) Study, a lower risk of incident diabetes or dysglycemia was also observed with accumulating
more steps/day [17, 18]. These studies focused on steps/
day and only one [19] examined how step cadence was
associated with diabetes risk. Additionally, it is unclear
how well findings from these studies generalize to more
diverse populations, especially among population groups
such as Hispanic/Latinos who have high rates of diabetes
[1]. Furthermore, only the OPACH study [19] of women
examined if associations varied by any risk factors for
diabetes such as age, obesity, prediabetes, and insulin resistance [1, 2, 20, 21]. Additionally, in populations
such as Hispanic/Latinos, occupational physical activity
is highly prevalent [22, 23] and findings have been mixed
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on if occupational physical activity is associated with a
lower risk of diabetes [6, 24–26].
Given the limited information on how stepping is associated with diabetes, we examined how steps/day were
associated with the risk of diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Furthermore, we examined if specific cohort characteristics (age, sex, occupational physical activity, obesity, insulin resistance, prediabetes, and Hispanic/Latino heritage)
modified the association between steps/day and diabetes.
Because steps/day is a combination of light, moderate,
and vigorous intensity steps, we further examined if step
cadence and stepping pattern (bouted stepping) were
associated with the risk of diabetes. We further explored
the impact of step intensity by examining if achieving the
same steps/day at a greater percent of intense steps compared to a lower percent of intense steps was associated
with a lower risk of diabetes. Chen et al. [7] observed
with the HCHS/SOL cohort a lower risk of diabetes with
more minutes spent in MVPA, but the steps/day relationship with diabetes has yet to be examined within the
cohort [7].

Methods
Study population

The HCHS/SOL is the largest population-based cohort of
Hispanic/Latino adults from four US metropolitan areas
(Bronx, NY; Chicago, IL; Miami, FL; San Diego, CA) [27,
28]. A total of 16,415 self-identified Hispanic/Latino
adults (18–74 years) were recruited and enrolled from
randomly selected households (2008–2011) through a
multistage area probability design. Visits were conducted
in 2008–2011 and 2014–2017 and at both visits, participants had a physical examination and completed questionnaires. Participants are also contacted annually over
the phone. The Institutional Review Boards approved
the study at each site and all participants gave written
informed consent.
Exposure

At baseline, participants were asked to wear an Actical
accelerometer (version B-1, model 198–0200-03) during
waking hours for 1 week. The Actical was attached to a
belt on the right hip and captured accelerations in 1-min
epochs. Non-wear was defined using the Choi algorithm
[29]. Participants left the examination visit wearing the
accelerometer and were told to undertake their usual
activities for the week and to remove the accelerometer
only during sleeping, showering, and swimming. The
data from 5 AM the day after the examination visit until
midnight on day 6 were included in the present analyses
to provide a consistent maximum 6-day wear period for
all participants. Accelerometer adherence was defined as
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at least 3 days with 10 h of wear. The 10 h criterion is often
used in other studies [30] and 3 of 6 days was selected to
represent at least half of the maximum days of wear [31].
Steps were determined by the manufacturer’s step algorithm. The Actical step function has performed well in
validation studies, although it may undercount steps at
slow walking speeds [32–34]. We averaged steps/day over
adherent days and calculated several cadence-based indicators of step intensity, including minutes spent at > 40
steps/min (purposeful steps and faster movement), > 70
steps/min (slow walking and faster movement), and > 100
steps/min (brisk walk and faster movement) [15]. We
derived peak 30-min cadence, representing the average
cadence of the 30 highest (but not necessarily consecutive) minutes in a day. We examined bouts of consecutive
minutes spent at different intensity levels (> 40 steps/min,
> 70 steps/min, and > 100 steps/min). A bout was defined
as > 10 consecutive minutes above the specified cadence
while allowing for interruptions of up to 20% of time
below the cadence threshold and less than 5 consecutive
minutes below the threshold [35]. The bout also had to
start and stop above the cadence threshold [36]. Interruptions allowed for real-life events such as stopping at
a traffic light or taking a water break during exercise [35].
We calculated the percent of steps that were at a cadence
of > 100 steps/min, termed ‘intense steps’, to examine
the contribution of intensity when holding steps/day
constant.
Outcome

We examined two definitions of incident diabetes in
order to enhance comparisons of our results with other
studies that have used various diabetes definitions.
The first definition was based on three criteria: 1) selfreported diagnosis of diabetes, 2) self-reported use of
diabetic medication, or 3) laboratory-tested fasting
plasma glucose > 126 mg/dl, non-fasting plasma glucose of > 200 mg/dl, 2-h postload oral glucose tolerance
test (OGTT) > 200 mg/dl, or glycosylated hemoglobin
(HbA1c) > 6.5% [37]. The second diabetes definition was
based on self-reported diabetic medication and laboratory values. Self-reported use of diabetic medication
and blood samples were collected at Visits 1 and 2. Selfreported diagnosis of diabetes, in addition to collection
at Visits 1 and 2, was also collected over eight annual
follow-up telephone interviews that occurred during the
time between Visits 1 and 2. Prevalent diabetes at baseline was defined using the three criteria definition. One
participant had data only for self-reported diagnosis and
not for diabetic medications and lab values; therefore,
the sample size for diabetes based on two criteria was
6633 rather than 6634. Further details are provided in
the Supplemental Methods.
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Covariates

We included the following covariates assessed at baseline
in our analysis: age, sex, Hispanic/Latino heritage, HCHS/
SOL field center, education, marital status, employment,
years lived in the US, self-rated general health, mobility
limitations, cigarette packyears, alcoholic drinks per week,
energy intake, the 2010 Alternative Healthy Eating Index
(AHEI-2010), body mass index (BMI), insulin resistance
as measured by homeostasis model assessment of insulin
resistance (HOMA-IR), prediabetes, and report of occupational physical activity, with description of the measures in
the Supplemental Methods.
Exclusions

Of the 16,415 enrolled participants, 11,623 attended
Visit 2. Of the Visit 2 participants, we excluded those
who had diabetes at baseline (n = 2541), did not wear
the accelerometer at Visit 1 (n = 732), were not adherent
to accelerometry (adherence was > 3 days with > 10 h of
wear; n = 1085), experienced an accelerometer malfunction (n = 62), and were missing any covariates used in
analysis (n = 515). We trimmed the top and bottom 1%
of the steps/day distribution in order to remove extreme
outliers (n = 54). After exclusions, the analytic sample
consisted of 6634 adults.
Statistical analysis

The HCHS/SOL study used a stratified two-stage area
probability sample design and oversampling occurred
at each stage (Supplemental Methods) [28]. All results
were adjusted for oversampling of specific population
subgroups and for nonresponse at Visit 2 by applying
sampling weights (Supplemental Methods). We further
adjusted for missing accelerometer data using inverse
probability weights (IPW) [38]. The IPWs predicted Actical adherence based on associated variables, as described
elsewhere (Supplemental Methods) [31]. The final
weight was a product of the sampling weight and IPW.
The weights were trimmed and calibrated to the 2010
US Census according to age, sex, and Hispanic/Latino
background in the Census block groups of the four
HCHS/SOL field centers. Results represent the characteristics of underlying population rather than the cohort
participants.
Cox proportional hazard models that accounted for
the complex survey design and survey weights were used
to estimate the association of step metrics with incident diabetes as hazard ratios (HR) and 95% confidence
intervals (CI). Follow-up time was calculated as time
from baseline to occurrence of incident diabetes, end of
follow-up, or death, whichever occurred first. The time
scale for all models was time since baseline. We tested
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the proportional hazards assumption by examining interactions between each step metric and follow-up time and
the assumption was met for all models. We further estimated incidence rates (IR) per 10,000 person-years with
Poisson models that accounted for the complex survey
design and survey weights. All analyses were conducted
with SAS version 9.4 and Stata version 15.0.
We examined continuous and categorical measures
of all step metrics. First, we examined the dose-response
association of steps/day, peak 30-min cadence, and minutes spent at different cadence with incident diabetes. For
each step metric, we tested for non-linearity by specifying
models with restricted cubic splines with knots at the 25th,
50th, and 75th percentile of the step metric distribution.
For all step metrics, the spline terms were not significant
suggesting the relationship between each step metric and
diabetes was not curvilinear [39]. In models with step metrics specified as a continuous variable, the 10th percentile
of the distribution was used as the referent group. Next,
we categorized steps/day based on the graduated step
index [40] (< 5000 (sedentary), 5000–7499 (low active),
7500–9999 (somewhat active), 10,000–12,499 (active),
and > 12,500 steps/day (highly active)). We classified peak
30-min cadence into four categories [15] (< 60 steps/min
(incident, sporadic, and purposeful movement), 60 - < 80
steps/min (slow walking), 80 - < 100 step/min (medium
walking), > 100 steps/min (brisk walking and faster ambulation)). We separately examined minutes spent above
> 40, > 70, and > 100 steps/min and specified categories
of minutes spent at different cadence as quartiles. For
minutes spent in bouts, we separately examined bouted
minutes above thresholds of > 40, > 70, and > 100 steps/
min. We included a category of no bouts and specified
remaining categories based on tertiles. For all step metrics
we estimated a p-value for trend by specifying each step
metric as an ordinal variable in models. All models were
adjusted for age, a quadratic term for age, sex, Hispanic/
Latino background by HCHS/SOL field center specified
as a 17-level categorical variable, education, married/partner status, employment status, years in the US, self-rated
general health, mobility limitations, cigarette pack years,
alcoholic drinks per week, energy intake, AHEI-2010, and
accelerometer wear time. We conducted sensitivity analyses by further adjusting for BMI, which we expected to
attenuate the association as a mediator.
We further explored the role of intensity by examining if having a greater percent of intense steps at a given
steps/day was associated with a lower risk of diabetes
than having a lower percent of intense steps at the same
steps/day (e.g., 7000 steps/day with 30% versus 10% of
these steps at ≥100 steps/min). All comparisons were
made to the referent of the 10th percentile of steps/day
and percent of intense steps (3400 steps/day and 1%).
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Last, we examined if the relationship between continuous
steps/day and diabetes varied by age (< 50, > 50 years), sex
(male, female), occupational physical activity (any, none),
obesity (not obese, obese), insulin resistance as measured by HOMA IR (normal, high), prediabetes status
(normal, prediabetes), and Hispanic/Latino background
(Dominican, Central American, Cuban, Mexican, Puerto
Rican, South American, Multi/Other). A likelihood ratio
test compared a model with an interaction term between
steps/day and the modifier to one without the interaction term and a p-value < 0.10 suggested the model with
the interaction term was a better fit [41]. Examination of
the stratum specific estimates were used to determine if
the relationship between steps/day and diabetes varied
within each modifier [42, 43]. The modification analysis with occupational physical activity was only among
adults who reported working full or part-time (n = 3799).

Results
The mean age of the cohort was 39 years, half were
female, 76% were born outside of the 50 US states, and
41% had prediabetes at baseline (Table 1). More than
half of the cohort reported being employed and among
employed adults, 53% reported any occupational physical activity. The average accelerometer wear time was
15.9 h/day (95% CI 15.7, 16.0). Adults had an average of
8164 steps/day (standard error = 92, median = 7317). On
average, adults spent 66, 27, and 12 min/day at a cadence
of > 40, > 70, and > 100 steps/min, respectively. Additionally, adults spent 24, 10, and 5 min in bouts at cadences of
> 40, > 70, and > 100 steps/min, respectively. The average
peak 30-min cadence was 77 steps/min.
Step volume with diabetes

Over a median of 5.9 years (range 1 to 9.6 years) of follow-up, there were 1115 (12.5%) and 740 (8.2%) incident
events of diabetes based on the two diabetes definitions.
Generally, incidence rates and HRs were lower with
greater steps/day; however, in the majority of analyses,
the confidence intervals included the null value (Table 2).
For diabetes based on three criteria, the risk of diabetes
was 2% lower (HR = 0.98 (95% CI 0.95, 1.00)) per 1000
steps/day. The predicted risk of diabetes at 7000 and
10,000 steps/day was 8% (HR = 0.92 (95% CI 0.85, 1.01))
and 13% (HR = 0.87 (95% CI 0.74, 1.02)) lower compared
to 3400 steps/day (Supplemental Table 1). Analyses with
steps/day based on the graduated step index suggested
an 18% lower risk of diabetes at 10,000–12,500 steps/
day (HR = 0.82 (95% CI 0.57, 1.18) compared to < 5000
steps/day. All results were similar for diabetes based on
two criteria. For both diabetes definitions, the addition
of BMI to models attenuated all associations of steps/day
with the risk of diabetes (Supplemental Table 2).
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Table 1 Descriptive characteristics at baseline for HCHS/SOL
cohort (2008–2017)
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Table 1 (continued)
N = 6634

N = 6634
Age (years), mean

% or mean

% or mean

95% CI

38.4

(37.8,39.1)

95% CI

Proportion of wear at different cadence, mean

Center, %

0 steps/min

69.0

(68.5,69.5)

1- < 40 steps/min

23.9

(23.5,24.3)

Bronx

27.7

(24.6,30.8)

40–99 steps/min

5.8

(5.6,6.0)

Chicago

15.3

(13.1,17.5)

  
> 100 steps/min

1.3

(1.2,1.3)

Miami

30.0

(25.9,34.2)

Minutes per day spent at different cadence, mean

San Diego

27.0

(23.4,30.6)

  
> 40 steps/min

66.4

(64.4,68.3)

  
> 70 steps/min

27.3

(26.2,28.4)

12.1

(11.4,12.8)

Hispanic/Latino heritage, %
Central American

7.8

(6.2,9.3)

  
> 100 steps/min

Cuban

20.4

(17.2,23.5)

Minutes per day spent in bouts at different cadence, mean

Dominican

9.5

(8.0,11.0)

  
> 40 steps/min

24.3

(22.9,25.7)

Mexican

38.4

(35.0,41.8)

  
> 70 steps/min

10.2

(9.5,11.0)

Puerto Rican

14.7

(12.9,16.6)

  
> 100 steps/min

4.8

(4.4,5.2)

South American

4.9

(4.1,5.7)

Multi/Other

4.3

(3.2,5.3)

Percent of steps > 100 13.5
steps/min, mean

51.6

(49.7,53.4)

29.0

(27.0,31.0)

Female, %
Education, %
  < high school/no
GED

28.0

(26.2,29.9)

  > high school

high school or GED

43.0

(40.6,45.3)

Married/partner, %

48.3

(46.0,50.6)

Employed, %

55.4

(53.4,57.4)

Reported any occupational physical
activitya, %

53.2

(50.0, 56.4)

Born in continental
US, %

24.1

(22.0,26.3)

BMI (kg/m2), mean

28.9

(28.7,29.2)

HOMA IR, mean

2.9

(2.8,3.0)

Have prediabetes, %

41.0

(39.1,42.9)

Excellent/very good

32.4

(30.5,34.4)

Good

46.5

(44.5,48.4)

Fair/poor

21.1

(19.5,22.7)

Have health/mobility
limitation, %

10.2

(8.9,11.5)

Cigarette pack years,
mean

4.0

(3.6,4.4)

Drinks per week,
mean

2.9

(2.6,3.2)

Energy intake (kcal/
day), mean

2023

(1999,2047)

Alternative Healthy
Eating Index, mean

47.1

(46.7,47.5)

Average wear time
(hours), mean

15.9

(15.7,16.0)

Daily steps, mean

8164

(7983,8344)

Peak 30 cadence
(steps/min), mean

77.2

(76.2,78.2)

General health, %

(12.9, 14.2)

Abbreviations BMI body mass index, HOMA IR homeostasis model assessment of
insulin resistance
a

Among participants who were employed (n = 3799)

Interactions of steps/day and modifiers with diabetes

For diabetes classified by three criteria, we observed modification by obesity (Fig. 1a, Supplemental Tables 3–4).
Adults with obesity had higher incidence rates of diabetes
than adults without obesity but adults with obesity who
accumulated 10,000 steps/day had 0.81 (95% CI 0.65,1.01)
times the risk of diabetes compared to adults with obesity who accumulated 3400 steps/day, while there was no
association among adults without obesity (HR = 1.01 (95%
CI 0.81, 1.27)).
For diabetes classified by two criteria, we observed
modification by age, sex, and prediabetes (Fig. 1b, Supplemental Tables 5–6). Among adults 50 and older, those
who accumulated 10,000 steps/day had 0.69(95% CI
0.52,0.90) times the risk of diabetes compared to those
who accumulated 3400 steps/day, while for younger
adults the inverse association was weaker (HR = 0.87
(95% CI 0.66, 1.14)). Among women, the HR at 10,000
steps/day was 0.67 (95% CI 0.49,0.92) compared to
women who accumulated 3400 steps/day while for men
there was a weaker inverse association (HR = 0.88 (95%
CI 0.68, 1.15)). Adults with prediabetes had higher incidence rates of diabetes than adults without prediabetes,
but adults with prediabetes who accumulated 10,000
steps/day had a 26% (HR = 0.74(95% CI 0.58,0.95)) lower
risk of diabetes than adults with prediabetes who accumulated 3400 steps/day, while there was no association
among adults without prediabetes (HR = 1.06 (95% CI
0.74, 1.52)). No modification was observed by occupational physical, HOMA IR, and Hispanic/Latino heritage.
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Table 2 The association of average daily steps and the graduated step index with incident diabetes, HCHS/SOL cohort (2008–2017)
diabetes based on self-reported diagnosis, medications,
labs (3 criteria definition)
n = 6634

diabetes based on medications and labs (2 criteria
definition)
n = 6633

num events sum p-years adjusted IR per HR (95% CI)
10,000 p-years

num events sum p-years adjusted IR per HR (95% CI)
10,000 p-years

Steps per day
  < 5000

323

10,049

9.5 (2.0, 44.4)

ref

223

10,519

3.4 (0.5, 23.1)

ref

5000 - < 7500

303

10,263

8.9 (1.9, 41.1)

0.94(0.73,1.22) 190

10,712

2.8 (0.4, 18.7)

0.81(0.60,1.10)

7500 - <  10,000

237

7843

9.9 (2.1, 47.7)

1.04(0.80,1.35) 158

8147

3.5 (0.5, 24.2)

1.01(0.72,1.41)

10,000 - < 12,500 116

4870

7.9 (1.6, 38.8)

0.82(0.57,1.18) 78

5056

2.2 (0.3, 14.9)

0.60(0.41,0.87)

5281

7.7 (1.6, 37.3)

0.81(0.58,1.14) 91

5464

2.3 (0.3, 16.3)

  
> 12,500

136

0.69(0.46,1.02)

p for trend

0.211

0.032

per 1000 steps

0.98(0.95,1.00)

0.97(0.94,1.00)

Models adjusted for age (continuous), quadratic term for age, sex (male, female), Latino background by HCHS/SOL field center (17 level categorical variable),
education (< high school/no GED, high school/GED, > high school), married/partner status (yes, no), employment (yes, no), years in the US (born in US, < 10 years, >
10 years), self-rated general health (excellent/very good, good, fair/poor), mobility limitations (yes, no), cigarette pack years (continuous), alcoholic drinks per week
(continuous), energy intake (continuous), AHEI-2010 (continuous) and accelerometer wear time (continuous, hours per day)
Abbreviations: CI confidence interval, HR hazard ratio, IR incidence rate, p-years person-years

Step cadence with diabetes

For both diabetes definitions, spending more time at > 70
and > 100 steps/min and having a faster peak 30-min
cadence were associated with a lower risk of diabetes
(Table 3). For example, accumulating at least 17 min/day
at > 100 steps/min was associated with a 31% (HR = 0.69
(95% CI 0.53,0.89)) lower risk of diabetes (three criteria
definition) compared to those who accumulated less than
2 min/day. For both diabetes definitions, the HR estimates
were generally lower with more time spent in bouts at
each cadence but the confidence intervals included the
null value for all analyses (Supplemental Table 7).
For both diabetes definitions, the addition of BMI to
models attenuated all associations of cadence-based metrics with the risk of diabetes (Supplemental Table 2).
Percentage of intense steps at a given step volume

Lower risk of diabetes was observed with greater steps/
day and a greater percent of intense steps at a given steps/
day level (Fig. 2). Compared to adults who accumulated
3400 steps/day and had 1% of intense steps, adults who

accumulated 7000 steps/day and had 10% of intense steps
had a 10% (HR = 0.90 (95% CI 0.82, 0.99)) lower risk,
whereas adults who accumulated the same steps/day but
had 30% of intense steps had a 18% (HR = 0.82 (95% CI
0.66, 1.02) lower risk of diabetes (three criteria definition)
(Supplemental Table 8). Findings were similar for diabetes based on two criteria.

Discussion
In this cohort of Hispanic/Latino adults, we observed
that taking more steps/day and spending more time at a
faster cadence were associated with a lower risk of developing diabetes. Our results suggest that adults had about
a 2 to 3% lower risk of diabetes per 1000 steps/day over
6 years. Our dose-response analysis suggested a gradual
decline in risk with more steps/day, such that any amount
of stepping was associated with a lower risk of diabetes
but greater risk reduction was achieved by taking more
steps/day. A faster peak 30-min cadence and more time at
faster cadences were also associated with a lower diabetes risk. Further, our results suggested that accumulating

(See figure on next page.)
Fig. 1 Hazard ratios and 95% CI of the association of steps/day with incident diabetes by modifying factors, HCHS/SOL cohort (2008–2017). a
Diabetes based on self-reported diagnosis, medications, labs (3 criteria definition, n = 6634). b Diabetes based on medications and labs (2 criteria
definition) n = 6633. Predicted estimates at the 2nd percentile (2000 steps/day), 25th percentile (5000 steps/day), 50th percentile (7000 steps/day),
75th percentile (10,000 steps/day), and 90th percentile (14,000 steps/day). Estimates compared to the 10th percentile (3400 steps/day) of steps/day.
Abbreviations: CI = confidence interval, HOMA IR = homeostasis model assessment of insulin resistance, LRT = likelihood ratio test, PA = physical
activity. All models adjusted for age (continuous), quadratic term for age, sex (male, female), Latino background by HCHS/SOL field center (17 level
categorical variable), education (< high school/no GED, high school/GED, > high school), married/partner status (yes, no), employment (yes, no),
years in the US (born in US, < 10 years, > 10 years), self-rated general health (excellent/very good, good, fair/poor), mobility limitations (yes, no),
cigarette pack years (continuous), alcoholic drinks per week (continuous), energy intake (continuous), AHEI-2010 (continuous) and accelerometer
wear . The model with occupational physical activity as a modifier is only among those who reported part- or full-time employment (n = 3799) and
does not include a covariate for employment, but otherwise is adjusted for the same covariates as other models

Cuthbertson et al. Int J Behav Nutr Phys Act

Fig. 1 (See legend on previous page.)

(2022) 19:46

Page 7 of 14

Cuthbertson et al. Int J Behav Nutr Phys Act

(2022) 19:46

Page 8 of 14

Table 3 The association of step cadence with incident diabetes, HCHS/SOL cohort (2008–2017)
Step metric - per day

diabetes based on self-reported diagnosis, medications,
labs (3 criteria definition) n = 6634

diabetes based on medications and labs (2
criteria definition) n = 6633

adjusted IR per 10,000
p-years

adjusted IR per 10,000
p-years

HR (95% CI)

HR (95% CI)

Peak 30 cadence, step/min
< 60

9.5 (2.1, 44.0)

ref

3.3 (0.5, 23.3)

ref

60 - < 80

8.7 (1.9, 40.0)

0.90(0.70,1.15)

2.9 (0.4, 19.6)

0.86(0.64,1.16)

80 - <  100

7.8 (1.7, 36.3)

0.79(0.62,1.02)

2.6 (0.4, 18.5)

0.75(0.55,1.02)

> 100

5.6 (1.2, 26.3)

0.58(0.41,0.82)

1.8 (0.2, 12.9)

0.56(0.35,0.89)

p for trend

0.001

0.006

per 10 step/min increase

0.95(0.91,0.99)

0.93(0.88,0.98)

Minutes spent at different cadence
  
> 40 steps/min, min per day
   < 33

9.2 (2.0, 42.9)

ref

3.0 (0.4, 20.6)

ref

   33 - < 55

9.3 (2.0, 43.4)

1.03(0.79,1.33)

2.9 (0.4, 19.8)

0.98(0.73,1.33)

   55 - < 87

8.5 (1.8, 40.4)

0.91(0.71,1.17)

2.8 (0.4, 18.8)

0.89(0.65,1.21)

   
> 87

7.4 (1.5, 36.0)

0.78(0.57,1.07)

2.0 (0.3, 13.3)

0.61(0.43,0.86)

p for trend

0.092

0.007

per 10 min

0.98(0.96,1.00)

0.97(0.94,1.00)

  
> 70 steps/min, min per day
   < 10

9.8 (2.1, 45.0)

ref

3.2 (0.5, 22.4)

ref

   10 - < 21

8.9 (2.0, 40.9)

0.92(0.71,1.18)

3.1 (0.5, 21.4)

0.99(0.73,1.34)

   21 - < 39

9.3 (2.0, 43.6)

0.96(0.75,1.23)

2.9 (0.4, 20.4)

0.88(0.66,1.17)

   
> 39

6.7 (1.5, 30.7)

0.68(0.51,0.91)

2.1 (0.3, 14.6)

0.65(0.45,0.94)

p for trend

0.024

0.016

per 10 min

0.95(0.90,1.00)

0.93(0.87,0.99)

  
> 100 steps/min, min per day
   < 2

9.8 (2.1, 44.9)

ref

3.5 (0.5, 24.2)

ref

   2 - < 7

9.3 (2.0, 43.3)

0.92(0.71,1.20)

3.0 (0.5, 20.4)

0.83(0.61,1.13)

   7 - < 17

8.8 (1.9, 40.4)

0.90(0.71,1.15)

3.2 (0.5, 21.9)

0.97(0.73,1.29)

   
> 17

6.8 (1.5, 30.9)

0.69(0.53,0.89)

2.1 (0.3, 14.6)

0.64(0.47,0.89)

p for trend

0.006

0.018

per 10 min

0.93(0.86,1.00)

0.92(0.83,1.02)

0.94(0.87,1.01)

0.95(0.86,1.04)

Percent of steps at > 100 steps/min, %
per 10%

Models adjusted for age (continuous), quadratic term for age, sex (male, female), Latino background by HCHS/SOL field center (17 level categorical variable),
education (< high school/no GED, high school/GED, > high school), married/partner status (yes, no), employment (yes, no), years in the US (born in US, < 10 years, >
10 years), self-rated general health (excellent/very good, good, fair/poor), mobility limitations (yes, no), cigarette pack years (continuous), alcoholic drinks per week
(continuous), energy intake (continuous), AHEI-2010 (continuous) and accelerometer wear time (continuous, hours per day)
Abbreviations: CI confidence interval, HR hazard ratio, IR incidence rate, p-years person-years

the same steps/day at a greater percent of intense steps
provided greater risk reduction than reaching the same
steps/day level with a lower percent of intense steps.
Thus, both volume and intensity may be important for
lowering the risk of diabetes. We found stronger associations between steps/day and reduced diabetes incidence
among adults at higher risk for diabetes, including older
adults and those affected by obesity and prediabetes.
Our inverse association between steps/day and diabetes is similar to findings from the NAVIGATOR Trial

where diabetes was defined by fasting glucose and 2-h
OGTT. In the NAVIGATOR study, 9306 participants
with impaired glucose tolerance, had a 4% (HR = 0.96
(95% CI 0.94, 0.99)) lower risk of diabetes per 2000 steps/
day (2% per 1000 steps/day) [16]. With diabetes defined
by medications and labs, we estimated a 3% lower risk per
1000 steps (HR = 0.97 (95% CI 0.94,1.00)). The OPACH
study estimated a HR of 0.88 (95% CI 0.78, 1.00) between
steps/day and diabetes defined by self-report of physician diagnosed diabetes requiring the need of insulin or
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hypoglycemic medication [19]. The AusDiab study also
examined steps/day and diabetes risk and observed a 13%
lower risk per 1000 steps/day of incident dysglycemia
over 5 years, but only two participants developed diabetes [17]. In a recent analysis with 3055 Swedish adults of
the Healthy Aging Initiative study, the authors observed a
59% (HR = 0.41 (95% CI 0.25, 0.66) lower risk of diabetes,
defined by International Classification of Disease codes,
for accumulating > 4500 steps/day compared to < 4500
steps/day [18]. Although our HR estimates suggest a
lower diabetes risk with greater steps/day, the confidence
intervals for many estimates did include the null value.
In addition to these studies on steps/day, there has
been consistent evidence on the inverse association of
self-reported physical activity with diabetes risk, but
more evidence is needed on the dose response relationship [5, 6]. A recent meta-analysis on self-reported
physical activity and diabetes risk observed that total
physical activity, as well as many subtypes of physical
activity (leisure-time activity, low, moderate, and vigorous intensity activity, walking, occupational activity, and
resistance exercise) were associated with a lower risk
of diabetes [6]. In the meta-analysis the dose-response
relationship of leisure-time activity with diabetes was
curvilinear, but there were too few studies to examine
the total physical activity dose response relationship
with diabetes [6]. In our analysis with HCHS/SOL,
total physical activity volume measured as steps/day
suggested a linear relationship with diabetes. A similar linear relationship was observed with the OPACH
study between steps/day and risk of diabetes [19]. With
the HCHS/SOL study, Chen et al. [7] examined accelerometer measured minutes in MPVA and observed a
curvilinear relationship with diabetes risk. We further
investigated this finding by examining the correlation
between steps/day and minutes in MVPA and found a
correlation of 0.66 (Supplemental Table 9). It is possible that the large amount of lower intensity activity that
makes up the step/day distribution may account for the
different dose response relationship between MVPA and
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steps/day with diabetes risk. However, further studies
should examine the shape of the relationship between
objectively measured total physical activity volume,
steps, and MVPA with incidence of diabetes.
It is hypothesized that physical activity may lower the
risk of diabetes through several biological mechanisms.
Greater amounts of physical activity may reduce adiposity, a risk factor for diabetes [6]. Additionally, both acute
and long-term physical activity increase glucose uptake
in skeletal muscle cells [44]. Muscle contractions, independent of insulin, increase glucose transport from blood
into skeletal muscle by translocation of the glucose transporters, especially glucose transporter 4 (GLUT4), from
the intercellular location to the plasma membrane [45].
Long-term physical activity is associated with adaptations to skeletal muscle, including an increase in GLUT4
protein levels and mitochondrial enzyme content, and
alteration of muscle fiber types that promote glucose
transport [44]. These mechanisms lend support to the
evidence that greater amounts of physical activity are
associated with a lower risk of diabetes.
Diabetes risk is higher among older age groups and
those with prediabetes or obesity [2, 20]. We found a
stronger inverse association between steps/day and diabetes risk for adults 50 years and older, and those affected
by obesity or prediabetes. In a previous HCHS/SOL
analysis, a lower risk of diabetes was also observed with
more accelerometer measured minutes spent in MVPA
among adults older than 50 years supporting this finding [7]. Exercise interventions among adults with obesity
and those with impaired fasting glucose have consistently
documented a lower diabetes risk with participation in
physical activity and diet interventions [46–48] and many
of these trials have noted stronger risk reduction among
older than younger adults [48, 49]. Our results suggest that adults at higher risk for diabetes, such as older
adults and those with prediabetes and obesity, should be
encouraged to engage in more steps/day to lower their
risk. A stronger inverse association between steps/day
and the risk of diabetes was observed for women than

(See figure on next page.)
Fig. 2 The association of steps/day and percent of intense steps (> 100 steps/min) with incident diabetes, HCHS/SOL cohort (2008–2017).
Compared to adults who accumulated 3400 steps/day and had 1% of intense steps (referent), a lower risk of diabetes was observed with greater
steps/day, and at a given steps/day, a lower risk was found with greater percent of intense steps. a Diabetes based on self-reported diagnosis,
medications, labs (3 criteria definition, n = 6634). b Diabetes based on medications and labs (2 criteria definition) n = 6633. Abbreviations:
CI = confidence interval. Steps/day predicted estimates at the 2nd percentile (2000 steps/day), 25th percentile (5000 steps/day), 50th percentile
(7000 steps/day), 75th percentile (10,000 steps/day), and 90th percentile (14,000 steps/day). Percent of intense steps (> 100 steps/min) predicted
estimates at 50th percentile (10%), 75th percentile (20%), and 90th percentile (30%). All comparisons made to the referent of the 10th percentile of
steps/day and percent of intense steps (3400 steps/day and 1%). Models adjusted for age (continuous), quadratic term for age, sex (male, female),
Latino background by HCHS/SOL field center (17 level categorical variable), education (< high school/no GED, high school/GED, > high school),
married/partner status (yes, no), employment (yes, no), years in the US (born in US, < 10 years, > 10 years), self-rated general health (excellent/
very good, good, fair/poor), mobility limitations (yes, no), cigarette pack years (continuous), alcoholic drinks per week (continuous), energy intake
(continuous), AHEI-2010 (continuous) and accelerometer wear time (continuous, hours per day)
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men. It is possible that other risk factors, such as hypercholesteremia that are more prevalent among men than
women in HCHS/SOL [50], may have may elevated diabetes risk more among men.
Our results regarding cadence, a proxy for step intensity, suggest that a higher peak 30-min cadence and more
time at a faster cadence were associated with a lower risk
of diabetes. Peak 30-min cadence has been described
as a summary of an individual’s best natural effort [15].
Adults with an average peak 30-min cadence of ≥100
steps/min, which is a cadence described as a brisk walk
or faster ambulation [15], had about a 40% lower risk of
diabetes compared to adults who had an average peak
30-min cadence of less than 60 steps/min. Additionally,
adults who accumulated > 39 min and > 17 min at > 70
and > 100 steps/min respectively, cadences described as
slow and brisk walking [15], were associated with about a
30% lower risk of diabetes compared to adults who accumulated less time at each of these cadences. The OPACH
study examined peak 30-min cadence and percent of time
at > 40 steps/min and did not find strong associations
between these cadence measures and the risk of diabetes [19]. The OPACH study also classified steps of light
and moderate-to-vigorous intensity using vector magnitude counts and observed a HR of 0.86 (95% CI 0.74,
1.00) between moderate-to-vigorous steps (per 2000 step
increment) and diabetes risk, but no association between
light steps and diabetes [19]. Two cross-sectional studies [51, 52] with the 2005–2006 National Health and
Nutrition Examination Survey data reported that greater
peak 30-min cadence was associated with improved cardiometabolic risk factors. We observed that more time
spent in stepping bouts was generally associated with a
lower risk of diabetes, however the confidence intervals
included the null value in all analyses. The OPACH study
found that steps that were accumulated in bouts of 5 min
or more were not associated with diabetes risk [19]. Few
studies reported on bouted stepping and diabetes risk,
but others have examined accelerometer-assessed MVPA
bouts with various health outcomes and found that total
volume of physical activity was more important than the
pattern of activity [53, 54].
In addition to observing a potential lower risk of diabetes with more steps/day, our results suggest that the
risk of diabetes was even lower when these steps were
accumulated at a higher intensity. Adults who accumulated 7000 steps/day with 10% versus 30% being intense
steps (≥100 steps/min) had a 10% versus 18% lower risk
of diabetes, respectively, compared to those accumulating 3400 steps/day with 1% being intense steps. At 7000
steps/day, 10 and 30% of intense steps are equivalent to
accumulating 700 and 2100 steps at a brisk walk or faster
pace which can be reached by taking a 7 min and 21 min
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brisk walk. In support of our finding, Strain et al. [55], in
the UK Biobank study, observed a lower risk of mortality
with greater physical activity volume and that accumulating the same volume with more intense activity rather
than lower intensity activity had even greater benefits.
Our study suggests that greater step intensity at a given
step volume is associated with a further risk reduction of
diabetes.
A strength of our study is that we focused on steps/
day, an easy-to-understand metric [9] that has become
more accessible due to increased activity tracker and
smartphone usage [56], and can motivate adults to
increase their physical activity [57]. Use of pedometers and activity trackers to monitor steps/day have
been an effective strategy to increase daily steps/day
[57, 58]. The common 10,000 steps/day goal present
on many activity trackers was not based on scientific
evidence but developed from the name of a Japanese
pedometer [59]. Currently, there are no guidelines that
provide recommendations on the number of steps/day
needed to achieve optimal health outcomes [9]. Some
research suggests that 7000–8000 steps/day are necessary to meet the aerobic physical activity guidelines
based on minutes spent in MVPA [60]. Research on
steps/day and health outcomes is quickly growing [11,
61] and our findings can contribute to future efforts to
develop evidence-based steps/day guidelines.
Our analysis is unique, as it was conducted with the
largest longitudinal Hispanic/Latino cohort. The Hispanic/Latino population accounts for 18% (60 million)
of the US population [62] and is projected to grow to
28% by 2060 [63]. A strength of our study is that we
used the Actical accelerometer to measure steps and
step cadence, rather than relying on self-report of
steps from pedometers. Because of the Actical accelerometer, which provided time-stamped data on step
accumulation, we were able to capture indicators of
step intensity and bouts, which has enabled further
understanding of how stepping patterns are associated
with the risk of diabetes. Additionally, we used two
definitions of diabetes and generally observed similar
results for both definitions.
There are limitations to our analysis to be considered.
Reverse causality cannot be ruled out as we are unable
to determine exactly when diabetes developed and
adults who developed diabetes close to baseline may
have lower steps/day. We used one measure of steps/
day and cadence and acknowledge that activity patterns
may change over time. However, data from the Women’s Health Study examined steps/day over 3 years and
found that a 7-day accelerometer collection of steps/
day was a reasonable estimate of longer-term physical activity [64]. Steps/day only captures ambulatory
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movement and not non-ambulatory movement, such
as any upper body movement while standing still, or
activities such as cycling or swimming. It is possible
that non-ambulatory movement may be beneficial for
preventing diabetes in addition to ambulatory movement. We examined if participants who were included
in our analysis were healthier than those excluded and
observed few differences in demographic and health
characteristics between the two groups. Additionally,
the sampling weights accounted for attrition and differences in accelerometer wear and adherence.

Conclusion
In conclusion, engaging in more steps/day and taking
more steps at a brisk walk or faster pace is potentially
associated with a lower risk of diabetes among US Hispanic/Latino adults. Our results suggest that adults
had a 2 to 3% lower 6-year risk of diabetes per 1000
steps/day -- any amount of stepping was associated
with a lower risk of diabetes but greater risk reduction
was achieved by taking more steps/day. The inverse
association between steps/day and diabetes risk was
observed across many cohort characteristics, most
prominently among adults at high risk for diabetes –
those who were older, or had obesity or prediabetes.
Accumulating the same steps/day at a greater percent
of intense steps was associated with further risk reduction. Our results suggest adults can lower their risk
of diabetes by taking more steps/day at any pace, but
should engage in brisk walking for part of their day to
gain the greatest benefit.
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